½ÃÀ庸°í¼­
»óǰÄÚµå
1589187

¼¼°èÀÇ ¹Ì¿ë ¼ºÇü ½ÃÀå : À¯Çüº°, ¼ú½Äº°, Á¦°ø¾÷üº° ¿¹Ãø(2025-2030³â)

Cosmetic Surgery Market by Type (Botox & Fillers, Brazilian Butt Lift, Breast Augmentation), Procedure (Non-Surgical Procedures, Surgical Procedures), Provider - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 199 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¹Ì¿ë ¼ºÇü ½ÃÀåÀº 2023³â 280¾ï 5,000¸¸ ´Þ·¯, 2024³â¿¡´Â 303¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.24%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 488¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì¿ë ¼ºÇüÀº ¿Ü°ú ¹× ºñ ¼ö¼ú ±â¼úÀ» ÅëÇØ ¿Ü°üÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·ÎÇÏ´Â ÀýÂ÷¸¦ Æ÷ÇÔÇϰí ÀÖÀ¸¸ç, ¹ÌÀû ¸Å·Â¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½À» ¸ñ°ÝÇÕ´Ï´Ù. ±× Çʿ伺Àº ¾Æ¸§´Ù¿òÀÇ ±âÁØ¿¡ ´ëÇÑ »çȸÀû °ü½É Áõ°¡, ¼Ò¼È ¹Ìµð¾îÀÇ ¿µÇâ, ³·Àº ħ½À ¼ö¼ú°ú °°Àº °í±Þ Ä¡·á¿¡ ´ëÇÑ ¾×¼¼½º Áõ°¡·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. À±°û Çü¼º, ¾È¸é Àç°Ç, dzÈä¼ú, ¾ÈƼ¿¡ÀÌ¡ Ä¡·á µî ´Ù¹æ¸é¿¡ °ÉÃÄ ±â´ÉÀû, ¹Ì¿ëÀû Çâ»óÀ» ¿ä±¸ÇÏ´Â ´Ù¾çÇÑ °í°´¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÅͱîÁö Æø³Ð°Ô ÇコÄɾî ÅëÇÕÀÇ ±¤¹üÀ§¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. µî ¼ö¼úÀÇ 3D À̹ÌÁö, AI, ·Îº¿ µîÀÇ ±â¼ú Çõ½ÅÀº Á¤È®¼ºÀ» ³ôÀϻӸ¸ ¾Æ´Ï¶ó ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ô¿© ´õ Å« ¼ö¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °íºñ¿ë, ±ÔÁ¦ Àå¾Ö¹°, À±¸®Àû ¿ì·Á, ÀáÀçÀû ÀÇ·á ÇÕº´Áõ µîÀÌ ÀÖ¾î ±¤¹üÀ§ÇÑ ½ÃÀå ħÅõ¿¡ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ´×ÀÇ Çʿ伺°ú ½ÃÀå Æ÷È­ÀÇ À§ÇèÀ» µé ¼ö ÀÖ½À´Ï´Ù.ºñÁî´Ï½º Âù½º´Â ¹ÌÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â ¹Ì°³Ã´ÀÇ ½ÅÈï °æÁ¦±Ç¿¡ ÀÖ¾î, °í±Þ µ¥ÀÌÅÍ ºÐ¼®¿¡ ÀÇÇØ °³º°È­µÈ ¹Ì¿ë ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â °Í¿¡ ÀÖ½À´Ï´Ù. ±â¾÷Àº º¸´Ù ³·Àº ħ½À ±â¼ú, ¿ø°Ý ÀÇ·á¿¡ ÀÇÇÑ È¯ÀÚ Ã¼Çè Çâ»ó, Áö¼Ó °¡´ÉÇÑ ¼ÒÀ縦 ÀÌ¿ëÇÑ Á¦Ç° °³¹ß µîÀÇ ¿¬±¸¸¦ ÅëÇØ Çõ½ÅÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù.AI¸¦ Ȱ¿ëÇÑ °³ÀÎÈ­µÈ ¹Ì¿ë ¼Ö·ç¼ÇÀº ½ÃÀå¿¡ Å« Â÷º°È­¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀ̸ç, Áö¼Ó°¡´É¼º°ú ±â¼úÅëÇÕ¿¡ ´ëÇÑ °ü½É Áõ°¡°¡ »õ·Î¿î ¼ºÀåÀÇ ±æÀ» °³Ã´ÇÑ´Ù´Â °ÍÀ» ½Ã»çÇϰí ÀÖ½À´Ï´Ù. Ȱ¿ëÇϱâ À§Çؼ­´Â ÀûÀÀ·Â°ú °æ°è½ÉÀ» À¯ÁöÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 280¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 303¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 488¾ï 6,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 8.24%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¹Ì¿ë ¼ºÇü ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¹Ì¿ë ¼ºÇü ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àúħ½À Àç°Ç ¼ö¼ú¿¡ÀÇ ±âÈ£ÀÇ °íÁ¶
    • ¼±Ãµ¼º ¾È¸éÀå¾Ö ¹× Ä¡±âÇüÀÇ ±ÞÁõ
    • ¹ÌÀû ¿Ü°ü¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀǽÄÀÇ ¼¼°è »ó½Â
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÒ¸®ÇÑ »óȯ Á¤Ã¥°ú ÀÓÇöõÆ®ÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ¹Ì¿ë ¼ö¼úÀÇ ±â¼úÀû Áøº¸
    • ¹Ì¿ë Åõ¾î¸®Áò¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ±âÈ£ÀÇ ³ô¾Æ
  • ½ÃÀåÀÇ °úÁ¦
    • ¹Ì¿ë Ä¡·á¿¡ µû¸¥ ºÎÀÛ¿ë

Porter's Five Forces : ¹Ì¿ë ¼ºÇü ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¹Ì¿ë ¼ºÇü ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¹Ì¿ë ¼ºÇü ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¹Ì¿ë ¼ºÇü ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¹Ì¿ë ¼ºÇü ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¹Ì¿ë ¼ºÇü ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¹Ì¿ë ¼ºÇü ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ¹Ì¿ë ¼ºÇü ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

¹Ì¿ë ¼ºÇü ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Àúħ½À Àç°Ç ¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø´Ù
      • ¼±Ãµ¼º ¾È¸é Àå¾Ö ¹× Ä¡¾Æ º¯Çü Áõ°¡
      • ¹ÌÀû ¿Ü°ü¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀǽÄÀÌ ¼¼°èÀûÀ¸·Î ³ô¾ÆÁö°í ÀÖ´Ù
    • ¾ïÁ¦¿äÀÎ
      • ºÒ¸®ÇÑ »óȯ Á¤Ã¥°ú ÀÓÇöõÆ®ÀÇ °í¾×ÀÇ ºñ¿ë
    • ±âȸ
      • ¹Ì¿ë ¼ö¼úÀÇ ±â¼úÀû Áøº¸
      • È­Àåǰ °ü±¤¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ±âÈ£ÀÇ °íÁ¶
    • °úÁ¦
      • ¹Ì¿ë Ä¡·á¿¡ µû¸¥ ºÎÀÛ¿ë
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¹Ì¿ë ¼ºÇü ½ÃÀå : À¯Çüº°

  • º¸Å彺¿Í ÇÊ·¯
  • ºê¶óÁú¸®¾È ¹öÆ® ¸®ÇÁÆ®
  • À¯¹æ ¼ö¼ú
  • À¯¹æ ¸®ÇÁÆ®
  • ÇǺΠ¹Ú¸®
  • ´«²¨Ç® ¼ö¼ú
  • ÆäÀ̽º ¸®ÇÁÆ®
  • À̸¶¿Í ´«½çÀÇ ¸®ÇÁÆ®
  • Áö¹æÈíÀÔ
  • ÄÚ ¼ºÇü
  • º¹ºÎ ¼ºÇü

Á¦7Àå ¹Ì¿ë ¼ºÇü ½ÃÀå ¼ø¼­º°

  • ºñ¿Ü°úÀû Ä¡·á
    • º¸Åø¸®´®Åö½Å(º¸Å彺)
    • ÇÇºÎ ÃæÀüÁ¦
    • ·¹ÀÌÀú Á¦¸ð
    • ¹Ì¼¼¹ÚÇǼú
    • Æ÷Åä ȸÃá
  • ¼ö¼ú ¼ö¼ú
    • À¯¹æ ¼ö¼ú
    • À¯¹æ ¸®ÇÁÆ®
    • ´«²¨Ç® ¼ö¼ú
    • Áö¹æÈíÀÔ
    • º¹ºÎ ¼ºÇü

Á¦8Àå ¹Ì¿ë ¼ºÇü ½ÃÀå : Á¦°ø¾÷üº°

  • º´¿ø°ú Àü¹® Ŭ¸®´Ð
  • ½ºÆÄ ¹× ¹Ì¿ë ¼ºÇü ¼¾ÅÍ

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¹Ì¿ë ¼ºÇü ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹Ì¿ë ¼ºÇü ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹Ì¿ë ¼ºÇü ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Adoderm GmbH
  • Aerolase Corp.
  • Allergan, Inc. by AbbVie Inc.
  • BENEV Company Inc.
  • Chromomogenex PLC
  • Cutera, Inc.
  • Genesis Biosystems, Inc.
  • Johnson & Johnson Services, Inc.
  • Merz/Anteis SA
  • MT.DERM GmbH
  • Plastic Surgical Group, PC
  • PPSD
  • Syneron Medical Ltd.
  • The Aesthetic Society
  • Westlake Dermatology & Cosmetic Surgery
BJH 24.11.21

The Cosmetic Surgery Market was valued at USD 28.05 billion in 2023, expected to reach USD 30.34 billion in 2024, and is projected to grow at a CAGR of 8.24%, to USD 48.86 billion by 2030.

Cosmetic surgery, encompassing procedures aimed at enhancing appearance through surgical and non-surgical techniques, is witnessing escalating demand driven by rising awareness of aesthetic appeal and technological advancements. The necessity arises from a growing societal focus on beauty standards, the influence of social media, and increased accessibility to advanced procedures like minimally invasive surgeries. Applications span across body contouring, facial reconstruction, breast augmentation, and anti-aging treatments, catering to a diverse clientele seeking both functional and cosmetic enhancements. End-use scope ranges from specialized clinics and hospitals to dermatological centers, underscoring a broad healthcare integration. Key growth factors include increasing disposable income enabling higher expenditure on such procedures, an aging population seeking youthful looks, and a burgeoning global middle class. Technological innovations such as 3D imaging, AI, and robotics in surgery not only enhance precision but also patient safety, promoting greater acceptance. However, market limitations encompass high costs, regulatory hurdles, ethical concerns, and potential medical complications, posing substantial barriers to broader market penetration. Challenges include the need for continuous training for surgeons on evolving technologies and the risk of market saturation in developed regions. Opportunities lie in untapped emerging economies with rising aesthetic awareness and in delivering personalized cosmetic solutions via advanced data analytics. Businesses can innovate through research into less invasive techniques, enhanced patient experience through telemedicine, and developing products with sustainable materials. Personalized beauty solutions leveraging AI could generate significant market differentiation. Insights suggest a dynamic market necessitating agile strategic approaches to cater to evolving consumer preferences and regulatory landscapes, with heightened focus on sustainability and technology integration paving new growth avenues. The cosmetic surgery market's nature is rapidly evolving, necessitating stakeholders to remain adaptive and vigilant to harness its full potential.

KEY MARKET STATISTICS
Base Year [2023] USD 28.05 billion
Estimated Year [2024] USD 30.34 billion
Forecast Year [2030] USD 48.86 billion
CAGR (%) 8.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cosmetic Surgery Market

The Cosmetic Surgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing preference for minimally invasive reconstruction surgeries
    • Proliferation in the number of congenital face disorders and tooth deformities
    • Growing consumer awareness about aesthetic appearance globally
  • Market Restraints
    • Unfavorable reimbursement policies and high cost of the implants
  • Market Opportunities
    • Technological advancements in cosmetic surgical procedures
    • Rising consumer preference for cosmetic tourism
  • Market Challenges
    • Side effects associated with cosmetic treatments

Porter's Five Forces: A Strategic Tool for Navigating the Cosmetic Surgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cosmetic Surgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cosmetic Surgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cosmetic Surgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cosmetic Surgery Market

A detailed market share analysis in the Cosmetic Surgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cosmetic Surgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cosmetic Surgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cosmetic Surgery Market

A strategic analysis of the Cosmetic Surgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cosmetic Surgery Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Aerolase Corp., Allergan, Inc. by AbbVie Inc., BENEV Company Inc., Chromomogenex PLC, Cutera, Inc., Genesis Biosystems, Inc., Johnson & Johnson Services, Inc., Merz/Anteis SA, MT.DERM GmbH, Plastic Surgical Group, PC, PPSD, Syneron Medical Ltd., The Aesthetic Society, and Westlake Dermatology & Cosmetic Surgery.

Market Segmentation & Coverage

This research report categorizes the Cosmetic Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Botox & Fillers, Brazilian Butt Lift, Breast Augmentation, Breast Lift, Dermabrasion, Eyelid Surgery, Facelift, Forehead & Brow Lift, Liposuction, Nasal Reshaping, and Tummy Tuck.
  • Based on Procedure, market is studied across Non-Surgical Procedures and Surgical Procedures. The Non-Surgical Procedures is further studied across Botulinum Toxin, Dermal Fillers, Laser Hair Removal, Microdermabrasion, and Photo-Rejuvenation. The Surgical Procedures is further studied across Breast Augmentation, Breast Lift, Eyelid Surgery, Liposuction, and Tummy Tuck.
  • Based on Provider, market is studied across Hospitals & Specialty Clinics and Spas & Cosmetic Surgery Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing preference for minimally invasive reconstruction surgeries
      • 5.1.1.2. Proliferation in the number of congenital face disorders and tooth deformities
      • 5.1.1.3. Growing consumer awareness about aesthetic appearance globally
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement policies and high cost of the implants
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cosmetic surgical procedures
      • 5.1.3.2. Rising consumer preference for cosmetic tourism
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with cosmetic treatments
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cosmetic Surgery Market, by Type

  • 6.1. Introduction
  • 6.2. Botox & Fillers
  • 6.3. Brazilian Butt Lift
  • 6.4. Breast Augmentation
  • 6.5. Breast Lift
  • 6.6. Dermabrasion
  • 6.7. Eyelid Surgery
  • 6.8. Facelift
  • 6.9. Forehead & Brow Lift
  • 6.10. Liposuction
  • 6.11. Nasal Reshaping
  • 6.12. Tummy Tuck

7. Cosmetic Surgery Market, by Procedure

  • 7.1. Introduction
  • 7.2. Non-Surgical Procedures
    • 7.2.1. Botulinum Toxin
    • 7.2.2. Dermal Fillers
    • 7.2.3. Laser Hair Removal
    • 7.2.4. Microdermabrasion
    • 7.2.5. Photo-Rejuvenation
  • 7.3. Surgical Procedures
    • 7.3.1. Breast Augmentation
    • 7.3.2. Breast Lift
    • 7.3.3. Eyelid Surgery
    • 7.3.4. Liposuction
    • 7.3.5. Tummy Tuck

8. Cosmetic Surgery Market, by Provider

  • 8.1. Introduction
  • 8.2. Hospitals & Specialty Clinics
  • 8.3. Spas & Cosmetic Surgery Centers

9. Americas Cosmetic Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cosmetic Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cosmetic Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adoderm GmbH
  • 2. Aerolase Corp.
  • 3. Allergan, Inc. by AbbVie Inc.
  • 4. BENEV Company Inc.
  • 5. Chromomogenex PLC
  • 6. Cutera, Inc.
  • 7. Genesis Biosystems, Inc.
  • 8. Johnson & Johnson Services, Inc.
  • 9. Merz/Anteis SA
  • 10. MT.DERM GmbH
  • 11. Plastic Surgical Group, PC
  • 12. PPSD
  • 13. Syneron Medical Ltd.
  • 14. The Aesthetic Society
  • 15. Westlake Dermatology & Cosmetic Surgery
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦